Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study

British Medical Journal

Volumn 333, Issue 7557, 2006, Pages 22-25

  Ebrahim, Shah ^a   Sung, Joohon ^b   Song, Yun Mi ^c   Ferrer, Robert ^d   Lawlor, Debbie A ^a   Smith, George Davey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Kangwon National University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; KOREA; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; RISK FACTOR; STROKE; BLOOD; DRINKING BEHAVIOR; EPIDEMIOLOGY; MIDDLE AGED;

ADULT; ALCOHOL DRINKING; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; EPIDEMIOLOGIC METHODS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 33745897916     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38855.610324.80     Document Type: Article

References (10)

1. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral haemorrhage in the general population. A systematic review. Stroke 2003;34:2060-6.
2. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995;346:1647-53.
3. Hart CL, Hole DJ, Davey Smith G. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke 1999;30:1999-2007.
4. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904-10.
5. Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez F, Lechat P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Int Med 2003;163:669-76.
6. Cholesterol Treatment Trialists' (CTT) Collaborators. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
7. Chen Z, Keech A, Collins R, Slavin B, Chen J, Campbell TC, et al. Prolonged infection with hepatitis B and association between low blood cholesterol concentration and liver cancer. BMJ 1993;306:890-4.
8. Reynolds K, Lewis LB, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003;289:579-88.
9. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality: confounding factors and risk modification in Japanese-American men. JAMA 1995;273:1926-32.
10. Hart CL, Davey Smith G, Hole DJ, Hawthorne VM. Alcohol consumption and mortality from all causes, coronary heart disease and stroke: results from a prospective cohort of Scottish men with 21 years of follow up. BMJ 1999;318:1725-9.